1. Home
  2. MRNS vs BNAI Comparison

MRNS vs BNAI Comparison

Compare MRNS & BNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNS
  • BNAI
  • Stock Information
  • Founded
  • MRNS 2003
  • BNAI 2018
  • Country
  • MRNS United States
  • BNAI United States
  • Employees
  • MRNS N/A
  • BNAI N/A
  • Industry
  • MRNS Biotechnology: Pharmaceutical Preparations
  • BNAI
  • Sector
  • MRNS Health Care
  • BNAI
  • Exchange
  • MRNS Nasdaq
  • BNAI NYSE
  • Market Cap
  • MRNS 29.9M
  • BNAI 27.3M
  • IPO Year
  • MRNS 2014
  • BNAI N/A
  • Fundamental
  • Price
  • MRNS $0.54
  • BNAI $0.63
  • Analyst Decision
  • MRNS Buy
  • BNAI Strong Buy
  • Analyst Count
  • MRNS 12
  • BNAI 1
  • Target Price
  • MRNS $4.28
  • BNAI $6.00
  • AVG Volume (30 Days)
  • MRNS 3.2M
  • BNAI 2.5M
  • Earning Date
  • MRNS 03-04-2025
  • BNAI 11-14-2024
  • Dividend Yield
  • MRNS N/A
  • BNAI N/A
  • EPS Growth
  • MRNS N/A
  • BNAI N/A
  • EPS
  • MRNS N/A
  • BNAI N/A
  • Revenue
  • MRNS $31,466,000.00
  • BNAI $135,000.00
  • Revenue This Year
  • MRNS $14.97
  • BNAI $189.69
  • Revenue Next Year
  • MRNS $57.65
  • BNAI $2,400.00
  • P/E Ratio
  • MRNS N/A
  • BNAI N/A
  • Revenue Growth
  • MRNS 1.63
  • BNAI 125.10
  • 52 Week Low
  • MRNS $0.22
  • BNAI $0.57
  • 52 Week High
  • MRNS $10.50
  • BNAI $19.75
  • Technical
  • Relative Strength Index (RSI)
  • MRNS 70.29
  • BNAI 38.40
  • Support Level
  • MRNS $0.54
  • BNAI $0.57
  • Resistance Level
  • MRNS $0.56
  • BNAI $1.18
  • Average True Range (ATR)
  • MRNS 0.02
  • BNAI 0.14
  • MACD
  • MRNS 0.01
  • BNAI -0.03
  • Stochastic Oscillator
  • MRNS 93.71
  • BNAI 9.24

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

About BNAI BRAND ENGAGEMENT NETWORK INC

Brand Engagement Network Inc is an innovative AI platform provider, designed to interface with emerging technologies, including blockchain, the Internet of Things, and cloud computing, that drive digital transformation across various industries and provide businesses with an unparalleled competitive edge. BEN offers a suite of configured and customizable applications, including natural language processing, anomaly detection, encryption, recommendation engines, sentiment analysis, image recognition, personalization, and real-time decision-making.

Share on Social Networks: